Will Trump's ‘Make in America’ order for essential medicines hurt Indian pharma?
US President Donald Trump has signed an executive order requiring the government to purchase locally made essential medicines and medical supplies. ET's Divya Rajagopal explains how this move affects Indian pharmaceutical companies. Watch
READ MORE:
Other Pharmaceuticals Videos
AI in Pharma: How India's Drug Giants Are Betting Big on Artificial Intelligence
The brutal leadership lesson that shaped Dr. Reddy’s chief
We are discovery rich, but development poor
Budget 2026: India’s pharma leap, BioPharma SHAKTI gets ₹10K cr; 1,000 clinical trial sites planned
Corner Office Conversation: Nandini Piramal of Piramal Pharma & Arjun Juneja of Mankind Pharma
